Diplomat Announces 1st Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. PANW
3. KEYS
4. MRK
5. KLAR
6. TGT
7. LOW
8. UBER
9. SPY
10. BIDU

Go back to Diplomat Announces 1st Quarter Financial Results

Leerink Partners Maintains OP Following Diplomat Pharmacy (DPLO) Q1

May 12, 2015 11:14 AM EDT

Leerink Partners maintains an Outperform rating on Diplomat Pharmacy (NYSE: DPLO), and raised the price target to $40.00 (from $36.00), following the release on the 1Q15 results. Diplomat reported an adjusted EPS of $0.09 (+57% y/y), which was $0.01 ahead of Leerink estimates and consensus. Total revenue of $625M increased +34% y/y. Revenue was slightly ahead of Leerink estimate
but below consensus.


Leerink analyst, David Larsen, commented on the... More

Diplomat Pharmacy (DPLO) PT Raised to $40 at Credit Suisse

May 12, 2015 8:03 AM EDT

Credit Suisse analyst G. Santangelo raised its price target on Outperform-rated Diplomat Pharmacy (NYSE: DPLO) to $40.00 (from $37.00) following Q1 'beat and raise'.

For an analyst ratings summary and ratings history on Diplomat Pharmacy... More

Diplomat Pharmacy (DPLO) Tops Q1 EPS by 1c; Boosts FY15 Outlook

May 11, 2015 4:08 PM EDT

Diplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $625 million versus the consensus estimate of $629.6 million.

Diplomat Pharmacy sees FY2015 EPS of $0.48-$0.51, versus prior guidance of $0.47-$0.50 and the consensus of... More